Getting Funded: The Fine Art Of Research Proposal Writing

The Mattia award was established in 1972 by Hoffmann La-Roche Inc. in honor of V.D. Mattia, who served as president and CEO of the company from 1965 to 1971 and was instrumental in setting up the molecular biology institute. Nine of the 25 winners to date have gone on to receive the Nobel Prize, the most recent being 1989 chemistry Nobelist Thomas Cech of the University of Colorado, Boulder, who received the Mattia award in 1987. R

Written byPeter Feibelman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Mattia award was established in 1972 by Hoffmann La-Roche Inc. in honor of V.D. Mattia, who served as president and CEO of the company from 1965 to 1971 and was instrumental in setting up the molecular biology institute. Nine of the 25 winners to date have gone on to receive the Nobel Prize, the most recent being 1989 chemistry Nobelist Thomas Cech of the University of Colorado, Boulder, who received the Mattia award in 1987.

Rothman, whose work has led to a better understanding of transmission of signals between brain cells and mechanisms of hormone release into the bloodstream, has devoted most of his career to elucidating the methods by which proteins are transported within cells. Over the course of his investigations, which began while he was at Stanford University in the late 1970s, he has studied all the stages involved in the process. He proposed a single underlying ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies